Exploring Kinases of Metabolism and Signaling in the Malaria Parasite Plasmodium
Amber Eubanks, Ph.D. candidate
Emily Derbyshire, advisor
Thursday, November 1, 2018 - 1:30pm to 3:30pm
Location: French Family Science Center 3232
Avery, Meg

Plasmodium is the causal agent of malaria, a parasitic disease that still affects millions of people annually. Unfortunately, parasite resistance has developed for all pharmaceuticals used to treat malaria. New parasite selective drugs with multi-stage inhibition of Plasmodium are required to combat resistance. The Plasmodium genome is unique and provides opportunities for novel drug targets, particularly the parasite kinases since they are critical regulators in signaling, cell cycle control, metabolism, and other pathways in eukaryotic systems.This work focuses on the Plasmodium atypical protein kinase 9, which has revealed unique roles in parasite signaling.